Navigation Links
Helmsley Charitable Trust awards more than $15 million to Salk Institute-CUMC
Date:11/3/2010

ls of disease will allow investigators from both institutions to screen at Columbia tens of thousands of chemical compounds to uncover novel drug therapies for hitherto untreatable diseases. The grant will therefore create a pipeline of new models and molecules that will start from individual patients and create new avenues back to the clinic.

Christopher E. Henderson, Ph.D., Director of the Columbia Stem Cell Initiative, and Co-Director of the Columbia Motor Neuron Center, said, "Although much public interest has been focused on the use of stem cells for tissue replacement, we and our collaborators at the Salk believe that in many clinical areas their major benefit will be to allow us to model diseases in the culture dish. Such cell-based models can generate new knowledge about the disease process itself, while also opening the way to high-throughput screening for test drug candidates."

Henderson added, "The Helmsley Trust support at Columbia will be focused on freeing up two key bottlenecks in this process. It will fund new protocols to allow scientists to transform stem cells into specific classes of differentiated cells, and will help support a facility that will allow researchers with a disease model to perform drug screening on a scale inaccessible in their own laboratories."

"The Helmsley Trust is showing great vision by investing in two scientific groups operating at the leading edge of stem cell research," said Salk Institute President William R. Brody. "We are deeply grateful to the trustees and look forward to a very fruitful collaboration with our Columbia University colleagues."

"The generosity of The Helmsley Trust enables research that ultimately may lead to prevention or treatment of diseases that currently have no cure," said Lee Goldman, M.D., Dean of the Faculties of Health Sciences and Medicine and Executive Vice President for Health and Biomedical Sciences at Columbia University Medical Center. "We look forwa
'/>"/>

Contact: Kat Kearney
kearney@salk.edu
858-453-410-01226
Salk Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Ten years on, Wellcome Trust launches study of 10,000 human genomes in UK
2. NIH and Wellcome Trust announce partnership to support population-based genome studies in Africa
3. Entrust Credentialing Services - A New End-to-End, SAAS Approach for Identity-Based Smartcards
4. Entrust Technology, Expertise Called on for Malaysian ePassport Project
5. Wellcome Trust funds dengue fever research in Leuven
6. Securing biological select agents and toxins will require developing a culture of trust
7. Arthritis Foundation of India Trust named winner of 2009 IOF Linda Edwards Memorial Award
8. Trust in a teardrop
9. Faculty of 1000 praised by Wellcome Trust
10. Entrusts New Code-Signing Certificates Enhance Trust in Applications, Software Developers
11. Public trust doctrine could aid management of US oceans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Helmsley Charitable Trust awards more than $15 million to Salk Institute-CUMC
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... , July 9, 2015  Unchained Labs ... announcing its acquisition of Avid Nano. Avid Nano ... scattering (DLS) systems.    Also today, ... fastest and easiest to use protein sizing system. ... measures a protein,s hydrodynamic size, size distribution, aggregation ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... infection via the innate immune system. Defensins are proteins ... anti-HIV activity. However, the mechanism by which the defensins ... on February 17 in advance of publication in the ... Investigation, Theresa Chang and colleagues from Mount Sinai School ...
... cancers from Nigeria, Senegal and North America has found ... be diagnosed with a more virulent form of the ... the University of Chicago, working with colleagues at the ... North Carolina, found that breast cancers in African women ...
... in the deep recesses of the world’s oceans. What ... cold and extreme pressure of such an environment? , ... of California, San Diego, and their colleagues have used ... accurate portrayal of deep sea life forms and how ...
Cached Biology News:Study reveals dramatic difference between breast cancers in US and Africa 2Study reveals dramatic difference between breast cancers in US and Africa 3Study reveals dramatic difference between breast cancers in US and Africa 4Advancements In Genomics Foster Deep Sea Discoveries 2
(Date:7/28/2015)... July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... it has granted to German life sciences entrepreneurs ... and commercialization of biotechnology (collectively, the "Optionee"), an ... allogenic tumor vaccine technology (the "Technology"), including AEZS-120, ... which is ready to enter a Phase 1 ...
(Date:7/28/2015)... SINGAPORE , July 28, 2015  Faced ... treatments that are palliative rather than symptomatic, the ... With few existing therapies capable of curing or ... providers are starting to look towards regenerative medicine ... represents a new paradigm in human health with ...
(Date:7/27/2015)... /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or ... for the treatment of cancer, today provides the following ... closed a $1,000,000 unit offering private placement.  This financing ... the Company at a price of $0.06 per unit.  ... one common share purchase warrant.  Each whole warrant is ...
(Date:7/27/2015)... MILWAUKEE, Wis. (PRWEB) , ... July 27, 2015 ... ... product and facility identification solutions, today announced a new video: 3 Ways ... with OSHA’s Hazard Communication Standard and the Globally Harmonized System (GHS) by effectively ...
Breaking Biology Technology:Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5Quest PharmaTech Closes $1,000,000 Private Placement 2Brady Releases “3 Roads to GHS Labels” Video 2
... Oct. 29 Elekta, a global leader ... Infinity*, the definitive new digital linear accelerator ... (VMAT), a very,fast Intensity Modulated Radiation Therapy ... at the 49th Annual Meeting of The ...
... FAJARDO, Puerto Rico and CORONA, Calif., Oct. ... Watson Pharmaceuticals, Inc. announced,today that under a ... Inc., Watson has launched Tilia(TM) Fe (norethindrone ... fumarate tablets), the generic,version of Warner Chilcott,s ...
... ... Exhibition, SAN ... in regenerative medicine, announced today that findings from,a preclinical study being ... Exhibition demonstrate the ability,of the Tengion Neo-Bladder Augment(TM) to restore bladder ...
Cached Biology Technology:Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors 2Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors 3Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 2Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 3Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe 4Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 2Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function 3
... Genetic Analysis System, which processes two 96-well plates ... adds a higher level of throughput to the ... of Beckman Coulters new GenomeLab family of products*, ... Biomek series liquid handers, for increased automation. ...
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...
... Studio Enterprise is integrated informatics solution ... mechanisms and drug response modeling. This ... worlds largest knowledge base of biological ... MedScan module capable of extracting pathway-related ...
Application: For use as a carrier in nucleic acid purification and precipitation. Physical form: Solution in 10 mM Tris HCl, pH 7.4, 1 mM EDTA Concentration: 9-11 mg/mL Physical Form: buffered aqu...
Biology Products: